These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 641370)

  • 1. Simple screening test for estimation of some phenolic and indolic compounds in urine application to melanoma.
    Pavel S; Matous B; Duchon J
    J Invest Dermatol; 1978 Apr; 70(4):197-9. PubMed ID: 641370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple and sensitive test for the determination of phenolic compounds in urine and its application to melanoma.
    Gan EV; Haberman HF; Menon IA
    J Invest Dermatol; 1975 Mar; 64(3):139-44. PubMed ID: 1117172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative gas chromatographic analysis of substituted 5,6-dihydroxyindoles from the urine of patients with melanoma.
    Pavel S; Muskiet FA; Budesínská A; Duchon J
    Tumori; 1981 Aug; 67(4):325-32. PubMed ID: 6797117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Excretion of phenolic and indolic compounds in hamsters with experimental melanoma (author's transl)].
    Pavel S; Schwippelová Z; Drechslerová E
    Sb Lek; 1979 Jan; 81(1):11-8. PubMed ID: 424678
    [No Abstract]   [Full Text] [Related]  

  • 5. Eumelanin-related indolic compounds in the urine of treated melanoma patients.
    Pavel S; Elzinga H; Muskiet FA; Smit JM; Mulder NH; Koops HS
    J Clin Chem Clin Biochem; 1986 Mar; 24(3):167-73. PubMed ID: 3711799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the excretion of phenolic and indolic substances in patients with malignant melanoma at the district hospital in Ustí nad Labem].
    Pavel S; Vyhnálková V; Matous B; Duchon J; Kubíková M
    Cesk Dermatol; 1980 Aug; 55(4):244-8. PubMed ID: 6157494
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C; Fiedler H; Wohlrab W; Wozniak KD
    Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the excretion of different types of melanogens in the melanoma patients.
    Matous B; Pavel S; Budĕsínská A; Duchon J; Mechl Z; Sopková B
    Neoplasma; 1979; 26(5):597-602. PubMed ID: 118388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of ester glucuronide and sulfate conjugates of 5-hydroxy-6-methoxyindole-2-carboxylic acid and 6-hydroxy-5-methoxyindole-2-carboxylic acid in melanoma urine.
    Wakamatsu K; Ito S
    J Dermatol Sci; 1990 Jul; 1(4):253-9. PubMed ID: 2095194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relations between the elimination of indolmelanogens and hydroxyindol particles in urine].
    Schwartze G
    Dermatol Monatsschr; 1970; 156(5):361-6. PubMed ID: 5509133
    [No Abstract]   [Full Text] [Related]  

  • 11. [Melanogens in the diagnosis of melanoma].
    Kubiński Z
    Nowotwory; 1987; 37(1):10-5. PubMed ID: 3628026
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE EXCRETION OF INDOLE MELANOGENS IN MALIGNANT MELANOM].
    Schwartze G; Grüneberg T
    Arch Klin Exp Dermatol; 1966 Jun; 225(2):207-17. PubMed ID: 5991618
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indole melanogens--useful tumor markers in malignant melanoma?].
    Ghussen F; Nagel K; Groth W; Horbach G
    Z Hautkr; 1985 Oct; 60(20):1613-9. PubMed ID: 4060826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neutral phenolic and indolic compounds in human urine.
    Borud O; Gjessing LR
    Scand J Clin Lab Invest; 1973 Mar; 31(2):237-45. PubMed ID: 4733200
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Thormählen-positive compound "B" in urine of patients with malignant melanoma.
    Pavel S; Boverhof R; van der Slik W
    Arch Dermatol Res; 1984; 276(3):156-9. PubMed ID: 6548107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemical diagnosis of melanoma].
    Agrup G
    Lakartidningen; 1976 Feb; 73(7):526-8. PubMed ID: 1250044
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
    Ito S; Wakamatsu K; Inoue S; Fujita K
    Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indole and phenol substances in urine of hamsters with transplantable melanotic melanoma (author's transl)].
    Pavel S; Matous B; Duchon J
    Sb Lek; 1977; 79(11-12):351-5. PubMed ID: 601504
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation of phenolic and indolic acids from untreated urine.
    Saini AS
    J Chromatogr; 1971 Feb; 54(3):442-5. PubMed ID: 5546379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.